Your trusted guide to fertility and reproductive health
IVF demands dozens of early-morning monitoring appointments, yet American work life offers little room for them. This opinion piece argues that access to fertility care is increasingly determined less by medicine than by the flexibility of your job.
Before you ever meet a physician, a clinic's website has already told you a great deal. Here are five marketing red flags to spot online — and what transparent communication looks like instead.
A failed first IVF cycle forces a reckoning — clinically and personally. This piece maps what actually changes between attempt one and attempt two, from protocol revisions to the follow-up questions worth asking before you recommit.
America's fertility industry was designed around a patient who, increasingly, does not exist: the married heterosexual couple. For single and LGBTQ+ prospective parents, the barriers are structural — in pricing, in insurance mandates, and in the assumptions baked into intake paperwork. Here is how to navigate a system that was not built for you.
Patients cannot tour the embryology lab, but the clues to its quality are hiding in plain sight — in default protocols, staffing ratios, and how willingly a clinic shares what happens to your embryos. Five signals worth decoding before you commit to a cycle.
Before the first injection or retrieval, IVF patients sign a stack of documents that determine who controls their embryos, what happens if they divorce or die, and how much liability a clinic actually carries. Here is what those pages really say — and the questions worth asking before your pen touches paper.
Preimplantation genetic testing has transformed how fertility specialists select embryos for transfer, but chromosomal normality is only one dimension of developmental competence. Two embryos that pass every genetic screen can still follow dramatically different paths once placed in the uterus — and the reasons why are only beginning to come into focus. Understanding the layers of biology that lie beneath a clean PGT-A result may be the next frontier in improving IVF outcomes.
Conventional fertility guidance has long centered on the moment of ovulation, but a growing body of research points to a critical window of egg readiness that begins hours before release. Understanding the distinction between nuclear and cytoplasmic maturation may hold significant implications for both natural conception and assisted reproductive technology protocols. Some fertility clinics are already adjusting their approaches in response.
Decades of IVF practice have operated on a straightforward assumption: more eggs retrieved means better odds of success. Emerging research is complicating that picture, revealing that aggressive stimulation protocols can introduce biological stressors that undermine the very eggs they were designed to produce. Understanding where the line falls between sufficient and excessive may be one of the most consequential decisions in a patient's treatment cycle.
Standard fertility testing can confirm that sperm look normal and eggs appear mature, yet fertilization still fails to occur. The reasons often lie at a molecular level that no routine lab report can capture. Understanding these hidden biological barriers can help patients make sense of unexpected outcomes in otherwise textbook-perfect cycles.
The freeze-all strategy—banking embryos rather than transferring immediately after retrieval—has quietly become one of the more consequential shifts in modern IVF practice. Understanding why some patients achieve better outcomes by waiting, rather than proceeding directly to a fresh transfer, requires a closer look at what egg retrieval actually does to the uterine environment. This article examines the science behind deferred transfers and how batch embryo testing is reshaping the way clinician
It is a natural assumption that retrieving more eggs in an IVF cycle will yield more viable embryos and better chances of success. The science, however, tells a more complicated story — one in which aggressive stimulation can compromise the very eggs it is designed to produce.
Most patients assume that freezing an embryo effectively pauses time — that a blastocyst stored for five years is biologically identical to one transferred the following month. Emerging research suggests the reality is more nuanced. Understanding what cryopreservation does and does not protect against may be one of the most consequential pieces of information a fertility patient can have.
Embryo arrest — when a developing embryo simply stops dividing and cannot progress — is one of the most disorienting outcomes a patient can face during an IVF cycle. Understanding why it happens, what stage-specific arrest patterns reveal, and when further investigation is warranted can help patients move forward with greater clarity and purpose.
Two patients. Two high-quality embryos. Two very different results. The emerging science of personalized endometrial receptivity assessment is challenging the assumption that a single transfer protocol works equally well for everyone. Here is what the research reveals — and what questions patients should be asking their care teams.
A standard semen analysis measures count, motility, and morphology — but these numbers tell only part of the story when it comes to IVF success. Emerging research on sperm function, DNA integrity, and molecular competence is revealing why some men with textbook-normal results encounter fertilization difficulties, while others with borderline parameters go on to achieve healthy embryos. Understanding what lies beyond the basic report may be one of the most consequential steps a couple can take be
Standard embryo grading captures a single snapshot in time, but development is a dynamic, continuous process. Time-lapse imaging technology now allows embryologists to track the precise timing of every cell division — a science called morphokinetics — offering a far more nuanced picture of which embryos are most likely to implant successfully. Here is what that data reveals, and why many patients never learn it exists.
Fertility clinics operate within a complex web of financial pressures, institutional protocols, and industry norms that can quietly narrow the options presented to patients. Understanding how these forces work—and knowing which questions to ask—may be among the most consequential steps you take on your reproductive journey.
Chronic, low-grade inflammation is increasingly recognized as a significant—and often overlooked—contributor to reduced fertility in both men and women. From compromising egg quality and sperm DNA integrity to disrupting the endometrial environment that a developing embryo depends upon, systemic inflammation affects nearly every stage of conception. Understanding how to identify and address this biological pattern may meaningfully improve outcomes for patients navigating fertility treatment.
Clinical guidelines suggest that a couple should seek evaluation after 12 months of trying to conceive, but the road from that first appointment to a working diagnosis — let alone a treatment plan — is rarely that straightforward. Administrative delays, diagnostic ambiguity, and the sheer biological variability of human reproduction routinely push timelines well beyond what any textbook anticipates. Understanding why that happens may be the most important thing a patient can do before the journe